News | Radiation Therapy | October 19, 2016

Ambient Experience uses modern technology and design to create a more comfortable and soothing experience for patients and staff during proton therapy

IBA, Philips, Ambient Experience, proton therapy, Proteus One, Proteus Plus, ASTRO 2016

October 19, 2016 — IBA (Ion Beam Applications SA) and Philips announced in September the launch of a dedicated patient-centric Ambient Experience solution for the proton therapy gantry of IBA’s Proteus Plus proton therapy solution. The announcement makes the Philips solution now available for both Proteus One and Proteus Plus.

Designed and engineered by Philips, Ambient Experience is an interactive, patient-focused healthcare environment that uses modern technology and people-centric design to create a more comfortable and soothing experience for patients and staff, helping to improve workflows and increase operational effectiveness. Implemented in IBA’s proton therapy gantries, patients are able to select their preferred theme, light, sound and video prior to undergoing treatment. By enhancing the clinical environment, Philips’ Ambient Experience improves patient comfort and staff experience and satisfaction. In 2014, Philips received an international Red Dot Award for product design for its dedicated Proteus One Ambient Experience solution.

The new Ambient Experience development is part of a broader collaboration between the two companies that also includes the joint marketing and sales of IBA’s proton therapy solutions and Philips’ imaging and clinical informatics solutions.

"The Philips Ambient Experience is one of the many differentiators of the Proteus One solution,” said Lane Rosen, M.D., at Willis-Knighton Cancer Center in Shreveport, La., the first IBA center to use Philips Ambient Experience. “Patients have the ability to change their color themes, music and video. Our patients enjoy the experience as it helps them to relax during treatment and remain still. The Ambient Experience atmosphere is calming for the staff as well as the therapist for this most meticulous of treatments."

"Cancer treatment can be a frightening experience, so making the environment as pleasant as possible is essential to reduce stress,” said Prof. Karol Sikora, chief medical officer of U.K.-based Proton Partners International, which is currently building three proton therapy centers. “We believe lighting, design and music will help to create a relaxing and soothing experience. And it will make our staff more relaxed too, by creating an atmosphere of greater empathy. We look forward to operating our first center with Philips Ambient Experience next year in Newport, Wales."
 
In 2016, IBA and Philips plan to equip four additional rooms in the United States: three Proteus Plus rooms in the Miami Cancer Institute, and one Proteus One at the Beaumont Hospital in Royal Oak, Mich. In addition, Philips and IBA have a pipeline of rooms to be equipped with Philips Ambient Experience features in the U.K., Middle East, U.S. and Taiwan.

For more information: www.iba-worldwide.com, www.usa.philips.com/healthcare


Related Content

News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
News | Radiation Oncology

February 12, 2024 — Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its ...

Time February 12, 2024
arrow
Subscribe Now